Eiko LifeSciences Limited (BOM:540204)
51.79
-0.85 (-1.61%)
At close: Jul 28, 2025
Eiko LifeSciences Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Cash & Equivalents | 117.81 | 133.46 | 6.12 | 2.17 | 40.72 | Upgrade |
Short-Term Investments | - | - | - | - | 24.72 | Upgrade |
Cash & Short-Term Investments | 117.81 | 133.46 | 6.12 | 2.17 | 65.44 | Upgrade |
Cash Growth | -11.73% | 2079.30% | 181.82% | -96.68% | 1241.42% | Upgrade |
Accounts Receivable | 107.86 | 131.34 | 71.06 | 45.62 | 34.15 | Upgrade |
Other Receivables | - | - | - | - | 3.96 | Upgrade |
Receivables | 107.86 | 131.34 | 71.06 | 45.62 | 38.11 | Upgrade |
Inventory | 57.75 | 33.86 | 9.08 | 54.58 | 0.64 | Upgrade |
Prepaid Expenses | - | 0.06 | 0.6 | 0.19 | - | Upgrade |
Other Current Assets | 45.36 | 10.57 | 6.16 | 31.95 | 2.83 | Upgrade |
Total Current Assets | 328.77 | 309.29 | 93.01 | 134.51 | 107.02 | Upgrade |
Property, Plant & Equipment | 231.19 | 135.65 | 138.81 | 142.89 | 2.48 | Upgrade |
Long-Term Investments | 71.54 | 40.18 | 11.76 | 58.67 | 20.29 | Upgrade |
Long-Term Deferred Tax Assets | - | - | - | - | 0.24 | Upgrade |
Other Long-Term Assets | - | 41.42 | 43.7 | - | - | Upgrade |
Total Assets | 661.01 | 527.39 | 310.43 | 348.94 | 166.14 | Upgrade |
Accounts Payable | 33.15 | 13.81 | 10.45 | 13.49 | 18.95 | Upgrade |
Accrued Expenses | 1.68 | 0.33 | 0.86 | 0.65 | 3.17 | Upgrade |
Short-Term Debt | 7.55 | - | - | 45 | 16.31 | Upgrade |
Current Portion of Long-Term Debt | - | - | 0.54 | 0.75 | 0.68 | Upgrade |
Current Income Taxes Payable | 2.36 | 0.64 | - | - | 0.49 | Upgrade |
Other Current Liabilities | 17.92 | 0.27 | 0.14 | 0.18 | - | Upgrade |
Total Current Liabilities | 62.65 | 15.05 | 11.99 | 60.06 | 39.6 | Upgrade |
Long-Term Debt | 20.08 | - | - | 0.54 | 1.28 | Upgrade |
Long-Term Deferred Tax Liabilities | 8.21 | 5.56 | 4.22 | 2.05 | - | Upgrade |
Other Long-Term Liabilities | - | - | - | -0 | - | Upgrade |
Total Liabilities | 90.95 | 20.61 | 16.21 | 62.64 | 40.88 | Upgrade |
Common Stock | 137.63 | 128.73 | 83.16 | 83.16 | 38.2 | Upgrade |
Additional Paid-In Capital | - | 344.06 | 184.58 | 184.58 | 12 | Upgrade |
Retained Earnings | - | 34 | 26.48 | 18.56 | 11.66 | Upgrade |
Comprehensive Income & Other | 430.26 | - | - | - | 63.4 | Upgrade |
Total Common Equity | 567.89 | 506.78 | 294.22 | 286.3 | 125.26 | Upgrade |
Minority Interest | 2.18 | - | - | - | - | Upgrade |
Shareholders' Equity | 570.06 | 506.78 | 294.22 | 286.3 | 125.26 | Upgrade |
Total Liabilities & Equity | 661.01 | 527.39 | 310.43 | 348.94 | 166.14 | Upgrade |
Total Debt | 27.63 | - | 0.54 | 46.28 | 18.27 | Upgrade |
Net Cash (Debt) | 90.17 | 133.46 | 5.59 | -44.1 | 47.18 | Upgrade |
Net Cash Growth | -32.44% | 2288.33% | - | - | - | Upgrade |
Net Cash Per Share | 6.94 | 12.94 | 0.57 | -5.65 | 12.35 | Upgrade |
Filing Date Shares Outstanding | 15.55 | 13.86 | 8.32 | 8.32 | 3.83 | Upgrade |
Total Common Shares Outstanding | 15.55 | 13.86 | 8.32 | 8.32 | 3.83 | Upgrade |
Working Capital | 266.11 | 294.24 | 81.03 | 74.45 | 67.42 | Upgrade |
Book Value Per Share | 36.53 | 36.56 | 35.38 | 34.43 | 32.73 | Upgrade |
Tangible Book Value | 567.89 | 506.78 | 294.22 | 286.3 | 125.26 | Upgrade |
Tangible Book Value Per Share | 36.53 | 36.56 | 35.38 | 34.43 | 32.73 | Upgrade |
Buildings | - | 38.57 | 38.29 | 38.11 | - | Upgrade |
Machinery | - | 89.7 | 87.28 | 85.2 | 5.15 | Upgrade |
Leasehold Improvements | - | 28.63 | 27.88 | 27.88 | - | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.